Endava Ltd. DAVA 深 沪
等待开盘 12-16 09:30:00 美东时间
6.96
+0.320
+4.82%
华盛通- 最 高7.00
- 今 开6.70
- 成交量 175.92万股
- 最 低 6.43
- 昨 收 6.64
- 总市值 3.78亿
- 52周最高 34.94
- 市盈率 静 14.93
- 换手率 0.00%
- 52周最低 6.02
- 委 比 0.00%
- 总股本 5432.76万
- 历史最高 172.41
- 量 比 2.00
- 振 幅 8.58%
- 历史最低 6.02
- 每 手 1
- 风险率 8.23%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 思科、On Holding、派拓网络等获多家机构上调目标价；Circle 遭富国、德银等多家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持PDS Biotechnology"买入"评级，目标价从13美元升至15美元；HC Wainwright & Co.：维持PepGen Inc."买入"评级，目标价从18美元升至20美元
11-14 10:43
Why Paysafe Stock Is Falling Today
Paysafe shares are plunging after a weak quarter, rising losses, heavy debt and a sharp cut to its 2025 outlook.
11-13 23:47
美股大行评级 | 富国银行上调AMD目标价升至345美元；花旗上调礼来目标价升至1500美元；巴克莱上调腾讯音乐目标价升至28美元
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从12美元升至15美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从106美元升至107美元
11-13 09:58
Needham Maintains Buy on Endava, Lowers Price Target to $9
Needham analyst Mayank Tandon maintains Endava (NYSE:DAVA) with a Buy and lowers the price target from $12 to $9.
11-12 19:30
电话会总结 ｜ Endava(DAVA)2026财年Q1业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Endava业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** 2025年第一季度（截至2025年9月30日）营收为1.782亿英镑，同比下降8.6%，按固定汇率计算下降7.3%。主要受到意外客户信贷调整和非战略管道机会转化率低于预期的影响。 **盈利能力：** 调整后税前利润为990万英镑，同比大幅下降48.4%（去年同期为1920万英镑）。调整后税前利润率从去年同期的9.9%下降至5.5%，压缩4.4个百分点。税前亏损850万英镑，而去年同期为盈利420万英镑。 **每股收益：** 调整后稀释每股收益为0.05英镑
11-12 12:35
William Blair Downgrades Endava to Market Perform
William Blair analyst Maggie Nolan downgrades Endava (NYSE:DAVA) from Outperform to Market Perform.
11-12 05:07
TRD U.S.A. Expands Collaboration With Endava As Its Official IT Consulting Partner In 2026, Beyond
TRD U.S.A. (Toyota Racing Development) is excited to announce a multi-year expanded partnership with Endava as their Official IT Consulting Partner in 2026 and beyond. Through this extended relationship, Endava will
11-11 20:46
Endava Lowers FY2026 Adj EPS Guidance from $1.11-$1.27 to $1.08-$1.19 vs $0.48 Est; Lowers FY2026 Sales Guidance from $1.013B-$1.033B to $992.267M-$1.014B vs $1.020B Est
Endava (NYSE:DAVA) lowers FY2026 Adj EPS guidance from $1.11-$1.27 to $1.08-$1.19 vs $0.48 analyst estimate. Lowers FY2026 sales outlook from $1.013 billion-$1.033 billion to $992.267 million-$1.014 billion vs $1.020
11-11 20:28
Endava Q1 Adj. EPS $0.18 Beats $0.08 Estimate, Sales $208.340M Miss $245.910M Estimate
Endava (NYSE:DAVA) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.08 by 125 percent. This is a 45.45 percent decrease over earnings of $0.33 per share from the same period
11-11 20:22
Earnings Scheduled For November 11, 2025
Companies Reporting Before The Bell • Gogoro (NASDAQ:GGR) is estimated to repor...
11-11 19:11
